← Evidence map

ReviewCancers2025

Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms.

Alessandro Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41228192